Patients' experiences with cancer care in Switzerland: Results of a multicentre cross-sectional survey.


Journal

European journal of cancer care
ISSN: 1365-2354
Titre abrégé: Eur J Cancer Care (Engl)
Pays: England
ID NLM: 9301979

Informations de publication

Date de publication:
Nov 2022
Historique:
revised: 02 09 2022
received: 11 12 2021
accepted: 07 09 2022
pubmed: 22 9 2022
medline: 30 11 2022
entrez: 21 9 2022
Statut: ppublish

Résumé

The objectives were to describe patients' experiences of cancer care in Switzerland and explore the variation of these experiences by type of cancer. The Swiss Cancer Patient Experiences (SCAPE) study was a cross-sectional, multicentre survey conducted in 2018. Adult patients (n = 7145) with breast, prostate, lung, colorectal, skin or haematological cancer from four large hospitals in French-speaking Switzerland were invited to complete a survey. Logistic regressions were used to assess whether experiences varied according to cancer type, adjusting for confounders. Of the 3121 persons who returned the survey (44% response rate), 2755 reporting an eligible cancer were included in the analyses. Participants' average score for overall care was 8.5 out of a maximum score of 10. Higher rates of positive experiences were found for nurse consultations (94%), diagnostic tests (85%) and inpatient care (82%). Lower positive responses were reported for support for people with cancer (70%), treatment decisions (66%), diagnosis (65%) and home care (55%). We observed non-systematic differences in experiences of care by cancer type. This large study identified that cancer patient experiences can be improved in relation to communication, information and supportive care aspects. Improvement efforts should target these areas of care to enhance responsiveness of cancer care.

Identifiants

pubmed: 36130722
doi: 10.1111/ecc.13705
pmc: PMC9787424
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Pagination

e13705

Subventions

Organisme : Swiss Cancer Research Foundation
ID : HSR-4354-11-2017

Informations de copyright

© 2022 The Authors. European Journal of Cancer Care published by John Wiley & Sons Ltd.

Références

Cancer Epidemiol. 2016 Apr;41:34-41
pubmed: 26797675
Pharm World Sci. 2005 Apr;27(2):96-103
pubmed: 15999919
J Patient Exp. 2020 Oct;7(5):758-765
pubmed: 33294612
Support Care Cancer. 2009 Aug;17(8):1117-28
pubmed: 19319577
Lancet Oncol. 2021 Jul;22(7):e327-e340
pubmed: 34000244
Eur J Cancer Care (Engl). 2018 Sep;27(5):e12874
pubmed: 29993149
Value Health. 2005 Mar-Apr;8(2):94-104
pubmed: 15804318
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13705
pubmed: 36130722
Support Care Cancer. 2016 Aug;24(8):3609-22
pubmed: 27137214
BMJ Open. 2019 Dec 16;9(12):e034344
pubmed: 31848175
Ann Oncol. 2013 Apr;24(4):1073-8
pubmed: 23136235
Ann Oncol. 2013 Aug;24(8):2151-8
pubmed: 23567145
J Natl Cancer Inst. 2021 May 4;113(5):523-531
pubmed: 32525530
BMC Health Serv Res. 2009 Oct 21;9:190
pubmed: 19845942
Eur J Oncol Nurs. 2020 Feb;44:101714
pubmed: 31954227
J Psychosoc Oncol. 2016 May-Jun;34(3):200-22
pubmed: 26983680
Med Care. 2001 Jun;39(6):635-41
pubmed: 11404646
J Clin Oncol. 2010 Sep 20;28(27):4154-61
pubmed: 20713876
Health Expect. 1998 Nov;1(2):82-95
pubmed: 11281863
Swiss Med Wkly. 2016 Apr 28;146:w14309
pubmed: 27124885
BMC Public Health. 2012 Jul 17;12:526
pubmed: 22800364
Lancet Oncol. 2012 Apr;13(4):353-65
pubmed: 22365494
Cancer Epidemiol. 2019 Aug;61:70-78
pubmed: 31153049
Br J Cancer. 2013 Aug 6;109(3):780-7
pubmed: 23807170
BMC Health Serv Res. 2015 Sep 28;15:425
pubmed: 26416612
Ann Oncol. 2011 Apr;22(4):761-772
pubmed: 20870912
Lung Cancer. 2020 Feb;140:27-34
pubmed: 31846785
BMC Health Serv Res. 2020 Nov 10;20(1):1029
pubmed: 33172451
Support Care Cancer. 2016 Apr;24(4):1719-28
pubmed: 26438144
Clin Breast Cancer. 2018 Jun;18(3):234-238
pubmed: 28888579
Cancer. 2017 Aug 1;123(15):2918-2926
pubmed: 28464268
Eur J Cancer. 2008 Jul;44(11):1559-65
pubmed: 18430563
Med Care. 2013 Aug;51(8 Suppl 3):S73-9
pubmed: 23774513
Eur J Cancer Care (Engl). 2015;24(1):85-98
pubmed: 25327713
Curr Oncol. 2017 Oct;24(5):332-337
pubmed: 29089801
Eur J Cancer Care (Engl). 2005 Mar;14(1):83-90
pubmed: 15698390
J Gen Intern Med. 1997 Jul;12(7):439-45
pubmed: 9229283
J Med Internet Res. 2019 May 02;21(5):e11855
pubmed: 31045503
BMC Cancer. 2016 Sep 02;16(1):711
pubmed: 27589989
Asia Pac J Oncol Nurs. 2020 Oct 15;8(1):5-17
pubmed: 33426184
Support Care Cancer. 2008 Aug;16(8):947-54
pubmed: 18204867
J Health Polit Policy Law. 2016 Aug;41(4):675-96
pubmed: 27127265
Psychooncology. 2013 Nov;22(11):2454-61
pubmed: 23733231
J Epidemiol Community Health. 2006 Jul;60(7):593-9
pubmed: 16790831
BMC Med. 2011 Jul 14;9:86
pubmed: 21756344
BMJ Open. 2014 Feb 14;4(2):e004567
pubmed: 24531454
Future Oncol. 2014;10(9):1589-98
pubmed: 24341422

Auteurs

Chantal Arditi (C)

Department of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Manuela Eicher (M)

Institute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Sara Colomer-Lahiguera (S)

Institute of Higher Education and Research in Healthcare (IUFRS), Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Christine Bienvenu (C)

Department of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Sandro Anchisi (S)

Oncology Service, Hôpital du Valais - Hospital Center of Valais Romand (CHVR), Sion, Switzerland.

Daniel Betticher (D)

Department of Oncology, HFR Fribourg - Cantonal Hospital, Fribourg, Switzerland.

Pierre-Yves Dietrich (PY)

Oncology Service, Geneva University Hospitals, Geneva, Switzerland.

Michel Duchosal (M)

Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Solange Peters (S)

Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Isabelle Peytremann-Bridevaux (I)

Department of Epidemiology and Health Systems, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH